YIH
PLRX icon

Y-Intercept (HK)’s Pliant Therapeutics PLRX Stock Holding History

Y-Intercept (HK)’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,471
Closed -$342K – 1552
2024
Q3 		$342K Buy
+30,471
New +$381K 0.02% 955
2023
Q2 		– Sell
-11,829
Closed -$315K – 1622
2023
Q1 		$315K Buy
+11,829
New +$337K 0.04% 749

Other funds holding PLRX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Y-Intercept (HK)'s PLRX Position: Q4 2024 in Review

Y-Intercept (HK) sold out of Pliant Therapeutics (PLRX) in Q4 2024, closing a stake of 30,471 shares — an estimated $342K sold.

Y-Intercept (HK) first reported a position in PLRX in Q1 2023 and held it in 2 quarters. The position peaked at $342K in Q3 2024. 160 funds tracked by Wall St. Rank hold PLRX as of Q4 2024.

  • Y-Intercept (HK) reported no remaining Pliant Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 30,471 Pliant Therapeutics shares in Q4 2024, an estimated $342K.
  • Y-Intercept (HK) first reported a position in Pliant Therapeutics in Q1 2023 and held it in 2 quarters.
  • Y-Intercept (HK)'s Pliant Therapeutics position peaked at $342K in Q3 2024.
  • 160 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2024.

Based on Y-Intercept (HK)'s 13F filing for Q4 2024, filed 4 Feb 2025.